מונטהלוקאסט טבע   10 מג ישראל - עברית - Ministry of Health

מונטהלוקאסט טבע 10 מג

abic marketing ltd, israel - montelukast as sodium - טבליות מצופות פילם - montelukast as sodium 10 mg - montelukast - montelukast - montelukast teva is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. montelukast teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast teva is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

קתדולון PR ישראל - עברית - Ministry of Health

קתדולון pr

salomon,levin & elstein ltd - flupirtine maleate 400 mg - tablets prolonged release - flupirtine - for use in acute and chronic pain, e.g. painful muscular tension in the postural and locomotor muscles .

אולנזפין טבע ® 5 מ"ג ישראל - עברית - Ministry of Health

אולנזפין טבע ® 5 מ"ג

salomon,levin & elstein ltd - olanzapine 5 mg - film coated tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

אולנזפין טבע ® 7.5 מ"ג ישראל - עברית - Ministry of Health

אולנזפין טבע ® 7.5 מ"ג

salomon,levin & elstein ltd - olanzapine 7.5 mg - film coated tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

אולנזפין טבע ® 10 מ"ג ישראל - עברית - Ministry of Health

אולנזפין טבע ® 10 מ"ג

salomon,levin & elstein ltd - olanzapine 10 mg - film coated tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva is indicated for the management of the manifestations of psychotic disorders. olanzapine teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanzapine teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

אולנזפין טבע ® 15 מ"ג ישראל - עברית - Ministry of Health

אולנזפין טבע ® 15 מ"ג

salomon,levin & elstein ltd - olanzapine 15 mg - film coated tablets - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

אולנזפין ODT טבע ® 5 מ"ג ישראל - עברית - Ministry of Health

אולנזפין odt טבע ® 5 מ"ג

salomon,levin & elstein ltd - olanzapine 5 mg - tablets orodispersible - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine odt teva is indicated for the management of the manifestations of psychotic disorders. olanzapine odt teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanzapine odt teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine odt teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

אולנזפין ODT טבע ® 10 מ"ג ישראל - עברית - Ministry of Health

אולנזפין odt טבע ® 10 מ"ג

salomon,levin & elstein ltd - olanzapine 10 mg - tablets orodispersible - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine odt teva is indicated for the management of the manifestations of psychotic disorders. olanzapine odt teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanzapine odt teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine odt teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

מונטהלוקאסט טבע ® 4 מ"ג ישראל - עברית - Ministry of Health

מונטהלוקאסט טבע ® 4 מ"ג

salomon,levin & elstein ltd - montelukast as sodium 4 mg - chewable tablets - montelukast - montelukast teva is indicated in pediatric patients 2 to 5 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.montelukast teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 2 to 5 years of age and older.

מונטהלוקאסט טבע ® 5 מ"ג ישראל - עברית - Ministry of Health

מונטהלוקאסט טבע ® 5 מ"ג

salomon,levin & elstein ltd - montelukast as sodium 5 mg - chewable tablets - montelukast - montelukast teva is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.montelukast teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 6 to 14 years of age and older.